The impact of macular pigment augmentation on visual performance using different carotenoid formulations J Loughman, JM Nolan, AN Howard, E Connolly, K Meagher, S Beatty Investigative ophthalmology & visual science 53 (12), 7871-7880, 2012 | 164 | 2012 |
The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS JM Nolan, J Loughman, MC Akkali, J Stack, G Scanlon, P Davison, ... Vision research 51 (5), 459-469, 2011 | 133 | 2011 |
Smartphone use as a possible risk factor for myopia S McCrann, J Loughman, JS Butler, N Paudel, DI Flitcroft Clinical and Experimental Optometry 104 (1), 35-41, 2021 | 129 | 2021 |
Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study EE Connolly, S Beatty, DI Thurnham, J Loughman, AN Howard, J Stack, ... Current eye research 35 (4), 335-351, 2010 | 123 | 2010 |
The relationship between macular pigment and visual performance J Loughman, MC Akkali, S Beatty, G Scanlon, PA Davison, V O’Dwyer, ... Vision research 50 (13), 1249-1256, 2010 | 122 | 2010 |
Changes in intraocular pressure and anterior segment morphometry after uneventful phacoemulsification cataract surgery I Dooley, S Charalampidou, A Malik, J Loughman, L Molloy, S Beatty Eye 24 (4), 519-527, 2010 | 105 | 2010 |
A review of the evidence germane to the putative protective role of the macular carotenoids for age‐related macular degeneration S Sabour‐Pickett, JM Nolan, J Loughman, S Beatty Molecular nutrition & food research 56 (2), 270-286, 2012 | 104 | 2012 |
The acceptability and visual impact of 0.01% atropine in a Caucasian population J Loughman, DI Flitcroft British journal of ophthalmology 100 (11), 1525-1529, 2016 | 96 | 2016 |
Supplementation with all three macular carotenoids: response, stability, and safety EE Connolly, S Beatty, J Loughman, AN Howard, MS Louw, JM Nolan Investigative ophthalmology & visual science 52 (12), 9207-9217, 2011 | 91 | 2011 |
Parental attitudes to myopia: a key agent of change for myopia control? S McCrann, I Flitcroft, K Lalor, J Butler, A Bush, J Loughman Ophthalmic and physiological optics 38 (3), 298-308, 2018 | 89 | 2018 |
Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration S Sabour-Pickett, S Beatty, E Connolly, J Loughman, J Stack, A Howard, ... Retina 34 (9), 1757-1766, 2014 | 87 | 2014 |
Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment JM Nolan, MC Akkali, J Loughman, AN Howard, S Beatty Experimental eye research 101, 9-15, 2012 | 80 | 2012 |
Augmentation of macular pigment following implantation of blue light–filtering intraocular lenses at the time of cataract surgery JM Nolan, P O'Reilly, J Loughman, J Stack, E Loane, E Connolly, S Beatty Investigative ophthalmology & visual science 50 (10), 4777-4785, 2009 | 79 | 2009 |
Novel myopia genes and pathways identified from syndromic forms of myopia DI Flitcroft, J Loughman, CF Wildsoet, C Williams, JA Guggenheim, ... Investigative ophthalmology & visual science 59 (1), 338-348, 2018 | 72 | 2018 |
Relationship between fear of falling and mobility varies with visual function among older adults OA Donoghue, H Ryan, E Duggan, C Finucane, GM Savva, H Cronin, ... Geriatrics & gerontology international 14 (4), 827-836, 2014 | 67 | 2014 |
Macular pigment optical density in an ageing Irish population: The Irish Longitudinal Study on Ageing JM Nolan, R Kenny, C O’Regan, H Cronin, J Loughman, EE Connolly, ... Ophthalmic research 44 (2), 131-139, 2010 | 65 | 2010 |
Macular pigment and its contribution to visual performance and experience J Loughman, PA Davison, JM Nolan, MC Akkali, S Beatty Journal of Optometry 3 (2), 74-90, 2010 | 65 | 2010 |
Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)—study protocol A Azuara-Blanco, N Logan, N Strang, K Saunders, PM Allen, R Weir, ... British Journal of Ophthalmology 104 (7), 950-955, 2020 | 58 | 2020 |
Macular pigment optical density is lower in type 2 diabetes, compared with type 1 diabetes and normal controls G Scanlon, P Connell, M Ratzlaff, B Foerg, D McCartney, A Murphy, ... Retina 35 (9), 1808-1816, 2015 | 52 | 2015 |
Evidence of lower macular pigment optical density in chronic open angle glaucoma E Igras, J Loughman, M Ratzlaff, R O'Caoimh, C O'Brien British Journal of Ophthalmology 97 (8), 994-998, 2013 | 52 | 2013 |